94506-3
LaboratorySARS-CoV-2 (COVID-19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
Definition
Quantitative results for detection of IgM antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum or plasma by immunoassay methods. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
LOINC 6-Axis Classification
Component
SARS coronavirus 2 Ab.IgM
Property
ACnc
Time Aspect
Pt
System
Ser/Plas
Scale Type
Qn
Method Type
IA
Details
Class
MICRO
Order/Observation
Both
Short Name
SARS-CoV-2 IgM SerPl IA-aCnc
Display Name
SARS-CoV-2 (COVID-19) IgM IA Qn
Related Names
Frequently Asked Questions
What is LOINC code 94506-3?
LOINC code 94506-3 identifies "SARS-CoV-2 (COVID-19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay". Quantitative results for detection of IgM antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum or plasma by immunoassay methods. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
What does 94506-3 measure?
This code measures SARS coronavirus 2 Ab.IgM in Ser/Plas. It belongs to the MICRO class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.